Limbach Holdings (LMB) Reports Q3 Loss of $0.46, Revenues Miss; Offers FY18 Revenue Mid-Point Outlook Below Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| Holmes Biopharma, Inc. (NASDAQ: LMB) | Delayed: 46.93 -1.47 (3.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $48.40 | 52 Week High | $0.15 | |||
| Open | $48.88 | 52 Week Low | $0.15 | |||
| Day High | $50.39 | P/E | N/A | |||
| Day Low | $46.75 | EPS | $0.00 | |||
| Volume | 152,963 | |||||
